Multiple Myeloma
DOWNLOAD FACT SHEET IN PDF

References:

1) Baur A, Stabler A, Nagel D. Magnetic Resonance Imaging as a Supplement for the Clinical
Staging System of Durie and Salmon? Cancer 2002;95:1334-1345 [PDF]

2) Durie BGM, Salmon SE. A Clinical Staging System for Multiple Myeloma. Cancer 1975;36:842-
854 [PDF]

3) Hanrahan CJ, Christensen CR, Crim JR. Current Concepts in the Evaluation of Multiple
Myeloma with MR Imaging and FDG PET/CT. Radiographics 2010;30:127-142 [PDF]

4) Fechtner K, Hillengass J, Delorme S. Staging Monoclonal Plasma Cell Disease: Comparison of
the Durie-Salmon and the Durie-Salmon PLUS Staging Systems. Radiology 2010;257:195-204
[PDF]

5) Walker R, Bargolie B, Haessler J. Magnetic Resonance Imaging in Multiple Myeloma:
Diagnostic and Clinical Implications. J Clin Oncol 2007;25:1121-1128 [PDF]

6) Rahmouni A, Divine M, Mathieu D. MR Appearance of Multiple Myeloma of the Spine Before
and After Treatment. AJR 1993;160:1053-1057 [PDF]

7) Moulopoulos LA, Dimopoulos MA, Alexanian R. Multiple Myeloma: MR Patterns of Response
to Treatment. Radiology 1994;193:441-446 [PDF]

8) Durie BGM, Kyle RA, Belch A. Myeloma management guidelines: a consensus report from the
Scientific Advisors of the International Myeloma Foundation. The Hematology Journal 2003;4:
379-398 [PDF]

9) Dimopoulos M, Terpos E, Comenzo RL. International myeloma working group consensus
statement and guidelines regarding the current role of imaging techniques in the diagnosis and
monitoring of multiple myeloma. Leukemia 2009;1:12 [PDF]

10) Durie BGM. The role of anatomic and functional staging in myeloma: Description of
Durie/Salmon plus staging system. European Journal of Cancer 2006;42:1539-1543 [PDF]

11) Baur-Melnyk A, Buhmann S, Durr HR. Role of MRI for the diagnosis and prognosis of multiple
myeloma. European Journal of Radiology 2005;55(1):56-63 [PDF]

12) Angtuaco EJ, Fassas ABT, Walker R. Multiple Myeloma: Clinical Review and Diagnostic
Imaging. Radiology 2004;231:11-23 [PDF]

13) Stabler A, Baur A, Bartl R. Contrast Enhancement and Quantitative Signal Analysis in MR
Imaging of Multiple Myeloma: Assessment of Focal and Diffuse Growth Patterns in Marrow
Correlated with Biopsies and Survival Rates. AJR 1996;167:1029-1036 [PDF]

14) Durie BGM, Waxman AD, A’Agnolo A. Whole Body 18F-FDG PET Identifies High-Risk
Myeloma. J Nucl Med 2002;43:1457-1463 [PDF]

15) Ehara S. Multiple Myeloma Seen Only on Multidetector CT. AJR 2003;180:281-282 [PDF]

16) Mahnken AH, Wildberger JE, Gehbauer G. Multidetector CT of the Spine in Multiple Myeloma:
Comparison with MR Imaging and Radiography. AJR 2002;178:1429-1436 [PDF]

17) Rahmouni A, Divine M, Mathieu D. Detection of Multiple Myeloma Involving the Spine:
Efficacy of Fat-Suppression and Contrast-Enhanced MR Imaging. AJR 1993;160:1049-1052 [PDF]

18) Hall MN, Jagannathan JP, Ramaiya NH. Imaging of Extraosseous Myeloma: CT, PET/CT, and
MRI Features. AJR 2010;195:1057-1065 [PDF]

19) Mulligan ME, Badros AZ. PET/CT and MR imaging in myeloma. Skeletal Radiology 2007;36:5-
16 [PDF]

20) Kim SH, Smith SE, Mulligan ME. Hematopoietic Tumors and Metastases Involving Bone.
Radiol Clin N Am 2011;49:1163-1183 [PDF]